Date(s) - 27/11/2018 - 28/11/2018
Global Engage is pleased to announce the Biologics and Biosimilars Congress Asia, co-located with Vaccines R&D and Commercialisation Congress Asia, which will take place in Singapore on the 27th and 28th November 2018. This event will feature over 30 expert speakers over two days and is expected to attract over 150 attendees and 20 poster presentations. This conference is part of Global Engage’s successful Drug Discovery series which includes our Precision Medicine, Medicinal Chemistry, and Synthetic Biology congresses.
The biologics theme will feature cutting-edge research on topics such as modern antibody-based therapeutics & engineering, immunotherapy, and protein biotherapeutics. Presentations on technological advancements such as antibody-drug conjugates (ADCs), success in monoclonal antibody (Mab) and antibody-derived therapeutics for chronic diseases will be extensively covered at the meeting. This field continues to show significant growth with an increasing number of clinical achievements across Asia.
Click here to read more.